Home › Funds › Almitas Capital LLC › BMEZ
Almitas Capital LLC position in BMEZ
BLACKROCK HEALTH SCIENCES TE · Financials
Almitas Capital LLC reported holding 507,095 shares of BMEZ (BLACKROCK HEALTH SCIENCES TE) in its Q2 2026 13F filing — a position valued at US$7.8M, representing 1.87% of its reported portfolio and ranking #11 among its reported holdings. Almitas Capital LLC has disclosed BMEZ holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Almitas Capital LLC's BMEZ position evolved
Almitas Capital LLC first disclosed a stake in BMEZ in Q3 2023 at 104,194 shares (US$1.5M). The position peaked in Q2 2024 at 1,761,943 shares, worth US$27.1M. Across 10 filings, Almitas Capital LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 507,095 shares valued at US$7.8M. Notable position changes include a 1141% increase in Q4 2023 (shares rose 12% over the following quarter), a 89% increase in Q2 2024 (shares rose 3% over the following quarter), a 231% increase in Q1 2026 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 104.19K | $1.50M | New |
| Q4 2023 | 1.29M | $18.95M | Add |
| Q1 2024 | 930.92K | $15.26M | Reduce |
| Q2 2024 | 1.76M | $27.06M | Add |
| Q3 2024 | 1.50M | $23.83M | Reduce |
| Q4 2024 | 1.34M | $19.29M | Reduce |
| Q1 2025 | 204.83K | $3.05M | Reduce |
| Q4 2025 | 152.91K | $2.30M | New |
| Q1 2026 | 506.39K | $7.27M | Add |
| Q2 2026 | 507.10K | $7.78M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMEZ and 13F data
BMEZ (BLACKROCK HEALTH SCIENCES TE) is a Financials company. 23 other funds we track also report a position in BMEZ — the largest reported positions include Saba Capital Management, L.P. (US$20.7M), RIVERNORTH CAPITAL MANAGEMENT, LLC (US$13.4M), CITY OF LONDON INVESTMENT MANAGEMENT CO LTD (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMEZ
- Saba Capital Management, L.P. 1.35M sh · $20.69M · Q2 2026
- RIVERNORTH CAPITAL MANAGEMENT, LLC 873.82K sh · $13.41M · Q2 2026
- CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 503.27K sh · $7.73M · Q2 2026
- Atlas Wealth LLC 499.70K sh · $7.67M · Q2 2026
- 1607 Capital Partners, LLC 442.21K sh · $6.79M · Q2 2026
- Z3 Capital Partners, LLC 393.51K sh · $6.04M · Q2 2026
More on Almitas Capital LLC
FAQ
How long has Almitas Capital LLC held BMEZ?
Almitas Capital LLC has disclosed BMEZ holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Almitas Capital LLC's current position in BMEZ?
As of Q2 2026, Almitas Capital LLC holds 507.10K shares of BMEZ (BLACKROCK HEALTH SCIENCES TE), valued at $7.78M, representing 1.87% of its reported portfolio and ranking #11.
Has Almitas Capital LLC been buying or selling BMEZ?
In the latest 13F filing (Q2 2026), Almitas Capital LLC held unchanged its position in BMEZ. The position peaked in Q2 2024 at 1.76M shares.
Which other funds hold BMEZ?
Other major institutional holders of BMEZ include Saba Capital Management, L.P., RIVERNORTH CAPITAL MANAGEMENT, LLC, CITY OF LONDON INVESTMENT MANAGEMENT CO LTD, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.